Evidence map›Paper›PMID 39118084›Full record

ArticleJournal of neuroinflammation2024

mTOR activation induces endolysosomal remodeling and nonclassical secretion of IL-32 via exosomes in inflammatory reactive astrocytes.

Kun Leng, Brendan Rooney, Frank McCarthy, Wenlong Xia, Indigo V L Rose, Sophie Bax, Marcus Chin, Saeed Fathi, Kari A Herrington, Manuel Leonetti and 4 more

Abstract read
In one paragraph

Article in Journal of neuroinflammation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Spatial transcriptomics identifies IL-32 as a lipid droplet-associated cytokine linked to tubular injury in human diabetic kidney disease.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Kun Leng *Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA. kun.leng@ucsf.edu.
Brendan Rooney *Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA.
Frank McCarthyChan Zuckerberg Biohub, San Francisco, CA, USA.
Wenlong XiaDepartments of Neurology and Pediatrics, School of Medicine, University of California, San Francisco, CA, USA.
Indigo V L RoseInstitute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA.
Sophie BaxChan Zuckerberg Biohub, San Francisco, CA, USA.
Marcus ChinMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.
Saeed FathiMedical Scientist Training Program, University of California, San Francisco, San Francisco, CA, USA.
Kari A HerringtonCenter for Advanced Microscopy, University of California, San Francisco, San Francisco, CA, USA.
Manuel LeonettiChan Zuckerberg Biohub, San Francisco, CA, USA.
Aimee KaoMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.
Stephen P J FancyDepartments of Neurology and Pediatrics, School of Medicine, University of California, San Francisco, CA, USA.
Joshua E EliasChan Zuckerberg Biohub, San Francisco, CA, USA.
Martin KampmannInstitute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA. martin.kampmann@ucsf.edu.

Funding

Medical Scientist Training Program (T32 NRSA Training Grant)T32GM141323 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Aimee Kao · 2021 to 2026
$10.5M
Systematic profiling of lysosomes with age to improve proteostasis in Alzheimer'sR01AG057342 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KAO, AIMEE · 2018 to 2022
$3.8M
Predoctoral Training in NeurobiologyT32NS115706 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SAMUEL JEREMY PLEASURE · 2020 to 2026
$3.4M
Systematic elucidation of endosomal trafficking as a therapeutic opportunity in AD using CRISPR-based functional genomicsR01AG062359 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KAMPMANN, MARTIN · 2018 to 2022
$3.2M
Vasculature provides the substrate for oligodendrocyte progenitor migration in development and diseaseR01NS097551 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FANCY, STEPHEN PHILIP JAMES · 2017 to 2021
$1.7M
Mechanisms of oligodendroglial ciliary function in white matter injury repairR01NS128021 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Stephen Philip James Fancy · 2023 to 2026
$1.6M
Astrocytes control the termination of oligodendrocyte precursor cell perivascular migration during CNS developmentR21NS133891 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FANCY, STEPHEN PHILIP JAMES · 2023 to 2023
$444k
Elucidating cellular pathways controlling the reactive state of astrocytes in Alzheimer’s DiseaseF30AG066418 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LENG, KUN · 2019 to 2023
$155k
California Institute of Regenerative Medicine EDUC4-12812Chan Zuckerberg Initiative Early Career Acceleration AwardNIA NIH HHS F30 AG066418NIA NIH HHS R01 AG057342NIA NIH HHS R01 AG062359NIGMS NIH HHS T32 GM141323NIH HHS F30 AG066418NIH HHS R01AG057342NIH HHS R01 AG062359NIH HHS R01NS097551NIH HHS T32 NS115706NINDS NIH HHS R01 NS097551NINDS NIH HHS R01 NS128021NINDS NIH HHS R21 NS133891NINDS NIH HHS T32 NS115706
6 · The paper itself

Abstract

Astrocytes respond and contribute to neuroinflammation by adopting inflammatory reactive states. Although recent efforts have characterized the gene expression signatures associated with these reactive states, the cell biology underlying inflammatory reactive astrocyte phenotypes remains under-explored. Here, we used CRISPR-based screening in human iPSC-derived astrocytes to identify mTOR activation a driver of cytokine-induced endolysosomal system remodeling, manifesting as alkalinization of endolysosomal compartments, decreased autophagic flux, and increased exocytosis of certain endolysosomal cargos. Through endolysosomal proteomics, we identified and focused on one such cargo-IL-32, a disease-associated pro-inflammatory cytokine not present in rodents, whose secretion mechanism is not well understood. We found that IL-32 was partially secreted in extracellular vesicles likely to be exosomes. Furthermore, we found that IL-32 was involved in the polarization of inflammatory reactive astrocyte states and was upregulated in astrocytes in multiple sclerosis lesions. We believe that our results advance our understanding of cell biological pathways underlying inflammatory reactive astrocyte phenotypes and identify potential therapeutic targets.

Indexed as

AstrocytesExosomesInterleukinsLysosomesTOR Serine-Threonine KinasesCells, CulturedEndosomesHumansInduced Pluripotent Stem CellsInflammationNeuroinflammatory DiseasesIL32 protein, humanInterleukinsMTOR protein, humanTOR Serine-Threonine KinasesAstrocytesEndolysosomal systemExtracellular vesiclesIL-32Inflammatory reactive astrocytesmTORNeuroinflammation

Identifiers

PMID39118084
PMCPMC11312292

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.